Rosy Future Predicted for Cannabis Research; Lab Launched to Support Clinical Trials

Cannabis is the one growth industry in the U.S. that you can count on. Recreational use of marijuana is now legal in many states. Moreover, there's increasing attention being paid to the medical uses of cannabis-based products. An Israeli lab has been set up to provide clinical validation for cannabis medical research (see:Israeli lab set up to give clinical validation to cannabis research). Below is an excerpt from an article on this topic:Israeli firm Asana Bio Group Ltd. has invested $2.3 million in a lab that will provide clinical trial services to companies that are developing a wide range of medical cannabis-based products in a bid to help them get widespread legitimacy....The initiative will be led by Prof. Lum ír Ondřej Hanuš, a Czech chemist and an authority in the field of cannabis research who has worked closely over the years in Israel with Prof. Raphael Mechoulam, considered a pioneer in cannabis research.Hanu š has identified and isolated all the active ingredients in the cannabis plant — more than 140 cannabinoids and over 1,000 other active substances....Cannabinoids are a class of medical compounds that act on cannabinoid receptors in cells in the brain....The establishment of a laboratory that provides clinical validity for research “is an important milestone for the cannabis industry in Israel and abroad,” said Yotam Hod, the CEO of Lumir Lab.“To date, the vast majority of cannabis products available in the various markets ...
Source: Lab Soft News - Category: Laboratory Medicine Authors: Tags: Clinical Lab Industry News Clinical Lab Testing Healthcare Innovations Lab Industry Trends Medical Research Pharmaceutical Industry Source Type: blogs